Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
November 7, 2022
Pear Therapeutics Presents Real-world Data Showing Reduction in Healthcare Resource Utilization and Associated Costs in Adults Using Somryst® at ISPOR Europe
November 7, 2022
Nouscom’s Personalized Neoantigen Cancer Immunotherapy NOUS-PEV Demonstrates Promising Safety, Immunogenicity and Anti-tumor Activity in Solid Tumors
November 7, 2022
Leading Fertility Company TMRW Life Sciences Receives FDA 510(k) Clearance for Next-Generation Technology to Safely Manage and Store Frozen Eggs and Embryos
November 7, 2022
Rallybio Announces Positive Phase 1 Single Ascending Dose Results for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5
November 3, 2022
Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE®) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101
November 3, 2022
State of Wisconsin to Provide Access to Prescription Digital Therapeutics to Help Local Communities Fight Against Addiction Crisis
October 27, 2022
Homology Medicines Presents on Design of pheEDIT Trial Evaluating One-Time Nuclease-Free Gene Editing Candidate HMI-103 for PKU at American Society of Human Genetics Meeting
October 27, 2022
Expansion Therapeutics Appoints Raymond Kelleher, M.D., Ph.D., to its Board of Directors
October 25, 2022
TMRW Life Sciences Launches World’s Most Advanced Specimen Management Facility for Frozen Eggs and Embryos Used In IVF
October 21, 2022
CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research
« Previous Page
1
…
18
19
20
21
22
…
119
Next Page »